Calcium and vitamin D deficiency impairs bone health and may cause rickets in children and osteomalacia in adults. Large animal models are useful to study experimental osteopathies and associated metabolic changes. We intended to modulate vitamin D status and induce nutritional osteomalacia in minipigs. The control group (n = 9) was fed a semisynthetic reference diet with 6 g calcium and 6,500 IU vitamin D 3 /kg and the experimental group (n = 10) the same diet but with only 2 g calcium/kg and without vitamin D. After 15 months, the deficient animals were in negative calcium balance, having lost bone mineral density significantly (means ± SEM) with −51.2 ± 14.7 mg/cm 3 in contrast to controls (−2.3 ± 11.8 mg/cm 3 ), whose calcium balance remained positive. Their osteoid surface was significantly higher, typical of osteomalacia. Their plasma 25(OH)D dropped significantly from 60.1 ± 11.4 nmol/L to 15.3 ± 3.4 nmol/L within 10 months, whereas that of the control group on the reference diet rose. Urinary phosphorus excretion and plasma 1,25-dihydroxyvitamin D concentrations were significantly higher and final plasma calcium significantly lower than in controls. We conclude that the minipig is a promising large animal model to induce nutritional osteomalacia and to study the time course of hypovitaminosis D and associated functional effects.
Introduction
Adequate calcium and vitamin D intakes are essential for skeletal health and to minimize the incidence of osteoporosis and of rickets in children and nutritional osteomalacia in adults. Calcium and vitamin D supplementation is also key to the treatment of these diseases [1] [2] [3] . Rickets and osteomalacia remain endemic problems in developing countries but show increasing prevalence also in North America and Europe [3, 4] because of changes in life style with an increase of indoor activities and a decrease in sunlight exposure. Incidence of osteomalacia is also increased by the 2 ISRN Rheumatology demographic shift, because calcium and vitamin D intakes are often inadequate in the elderly, in whom vitamin D synthesis, calcium absorption, and renal reabsorption tend to diminish [3] . Subjects with darker skin or covering clothing habits are at higher risk because both factors contribute to insufficient dermal vitamin D synthesis, responsible in turn for diminished bone density. Vitamin D combined with calcium has been shown to enhance lower-extremity function when vitamin D intake was sufficient to assure a serum concentration of 25-hydroxyvitamin D [25(OH)D] that exceeds 75 nmol/L [5] . This value is much higher than the current normative value of 25 nmol/L, on the basis of which the incidence of rickets/osteomalacia is minimized [1] . Calcium and vitamin D thus have additional metabolic functions, with vitamin D insufficiency now recognized to be associated with several chronic diseases [5, 6] . How much vitamin D is needed to achieve an adequate value for plasma 25(OH)D is not well known, because the estimate of optimal vitamin D intake is complicated by several confounding factors that affect vitamin D status, beside age, diet, and sunlight exposure. Obviously there is no final consensus on the definition of hypovitaminosis, vitamin D deficiency or insufficiency and on what an optimal 25(OH)D level is [1, 5, 7] .
It is still difficult to distinguish osteoporotic changes from those of nutritional osteomalacia solely by noninvasive, radiological techniques (quantitative computed tomography, QCT). The loss of apparent bone mineral density (BMD) following rarefaction of trabecular bone, which often is amplified by a calcium and vitamin D shortage, like in osteoporosis, cannot be differentiated from a loss following impaired mineralization of bone tissue, like in moderate osteomalacia. The characteristic feature of nutritional osteomalacia is low bone matrix mineralization combined with enlarged thickness of osteoid tissue in the presence of chronic and severe vitamin D deficiency [1, 8, 9] .
Enlarged osteoid has to be verified histologically on bone biopsies as surface or volume [8, 9] . To facilitate differentiation of osteomalacia from other low-BMD diseases, like osteoporosis, changes in functional parameters of bone and mineral metabolism may be assessed by use of laboratory markers. Studying the time course of BMD and serum levels of 25(OH)D and 1,25(OH) 2 D in human subjects in response to varying calcium and vitamin D intakes requires an extensive and expensive experimental set-up and is limited by ethical issues. Investigations in animal models may help in this respect and provide a model for preclinical trials with agents modulating vitamin D metabolism and vitamin D actions. Experiments with rodents have yielded useful insights, but guidelines application to human therapy of bone diseases, like for osteoporosis, may require studies with larger animal models [10] . In previous publications [11] [12] [13] we reported on the utilization of the minipig as a large animal model in metabolic and bone studies including glucocorticoidinduced osteoporosis (GIO). We now report on the long-term effects of vitamin D and calcium insufficiency on longitudinal and cross-sectional changes of bone mineral density and content, osteoid surface and parameters of bone metabolism compared to a reference group on sufficient intake of calcium and vitamin D. We aimed at assessing whether the minipig can be used for the study of nutritional osteomalacia and the modeling of vitamin D status.
Experimental Methods
The experiment was approved by the Ministerium für Umwelt, Natur und Forsten des Landes Schleswig-Holstein that regulates animal experiments. The experiment was part of a larger intervention trial with minipigs, in which we investigated the physiologic responses and the composition and properties of bone in this large animal model to various treatments [11, 13] .
Animals, Experimental Groups, and Time Schedule.
The experiment was initiated with two groups of ten female primiparous Göttingen minipigs, 30 months old, from the Institute's own breeding herd. They were matched for age and body weight. Blood, urine, and fecal samples were obtained, and BMD was determined at the beginning of the experiment and at regular intervals thereafter. Animals were sacrificed after 15 months, when bone specimens were obtained. One animal died during anaesthesia.
Diets, Housing, and Intervention.
Until the start of the study, the sows were on the Institute's regular feeding regimen for minipigs (standard diet, 580 g/d) that provided per kg diet: 5 g calcium, 4 g phosphorus, 50 g (2000 IU) cholecalciferol (vitamin D 3 ), and 9 MJ metabolizable energy. Accordingly, the vitamin D intake was 29 g/d (1,160 IU/d) before intervention. The sows were then assigned either to the control group [C] or to the deficient group [CaD(−)], getting 370 g/d of a semipurified diet. The control group was fed a reference diet that contained (g/kg diet) corn starch, 290; sucrose, 240; casein, 150; cellulose, 80; lard, 75; margarine, 75; mineral and vitamin premix, 60; lactulose, 30; and 14 MJ metabolizable energy. The diet contained 6 g/kg calcium, 7 g/kg phosphorus, and 160 g/kg (6,500 IU/kg) of vitamin D 3 (Deutsche Vilomix Tierernährung GmbH, Neuenkirchen-Vörden, Germany). Their vitamin D intake was 60 g/d (2,400 IU/d). The reference diet was different from a standard diet for pigs because we aimed to mimic a typical western diet (i.e., energy dense, rich in fat and protein, poor in fiber, Ca : P < 1), but with mineral and vitamin content sufficient for adult minipigs. This reference diet has been long used in our laboratory for experimental studies without any signs of side effects and was described before [14] . Its vitamin D content is higher than the standard diet for pigs or values recommended for humans, owing to the matter that less feed was supplied because of the higher energy density of the semisynthetic diet. Furthermore, the experiment was longtermed and without other oral or dermal vitamin D sources. The vitamin D dose remained below the upper tolerable level for humans of 4000 IU per day and assumed toxicity levels of 10,000 IU/day [1] . The diet was analyzed for protein, calcium, and phosphorus. Animals on the deficient diet were fed the same semisynthetic diet except that it contained only 2 g/kg calcium and no vitamin D 3 . For maintenance of body weights individual feed intake was restricted to 370 g/d, all was measured in EDTA plasma by radio-receptor assay (RRA) (Immundiagnostik, Bensheim, Germany). Values for intra-and interassay variability were 12% CV and 17% CV, respectively. Osteoprotegerin (OPG) was analyzed in serum by sandwich enzyme immunoassay (Immundiagnostik, Bensheim, Germany) in the samples at baseline and after eight months. Values for intra-and interassay variability were 9% CV and <10% CV, respectively, at a detection limit of 0.14 pmol/L. Bone alkaline phosphatase (BAP) was analyzed in heparin plasma as the difference between total alkaline phosphatase (AP) before and after lectin precipitation, with a kit (Roche Diagnostics GmbH, Mannheim, Germany) based on a kinetic color reaction. Values for intra-and interassay variability were 1.6% CV and 2.5% CV, respectively. Urine was collected for 24 h at 0 and 2 to 15 and stored frozen at −18 ∘ C until analysis. For this, minipigs were individually transferred to metabolic cages for 24 h that allowed the separate sampling of urine and feces. For technical reasons, urine samples of only 6 animals per group were collected at 2. Calcium and phosphorus were analyzed as described previously. Deoxypyridinoline (DPD) was determined by a preparative reverse-phase-column HPLC as described before [16] , using a commercially available bovine bone gelatin (Deutsche Gelatine-Fabriken Baden, Germany) as external standards. All plasma and urine parameters analyses were done in duplicate and blindly.
Mineral Balance.
Metabolic balances were performed at 0, 5, 10, and 15. Minipigs were transferred to metabolic cages for 7 days to allow separation of feces and urine. Samples were collected daily and stored at −18 ∘ C until analysis. Calcium and phosphorus absorption and retention were calculated on a mg/7-day basis as follows: absorption = intake − fecal excretion; retention = intake − (fecal excretion + urinary excretion). All analyses were done in duplicate and blindly.
Bone Mineral Density. (BMD) was assessed in vivo in
aneasthetized animals by quantitative computed tomography (QCT) with a Siemens Sensation 16 Scanner at 0, 8, and 15. Trabecular BMD values were evaluated in a central bone slice, 10 mm thick, and an elliptical region in the anterior part of lumbar vertebrae L1-L3. The Siemens OsteoPackage was used to calculate results. Reproducibility was assessed by duplicate measurements in 4 minipigs with interim repositioning. The root-mean-square (RMS) average of precision [17] was 0.83% (3.4 mg/cm 3 ). Bone strength was measured on the 4th lumbar vertebra (L4) as ultimate mechanical stress and calculated as failure load, divided by the cross-sectional area of the cylinders at the point of failure. Compression was tested on thawed cylindrical cancellous bone specimens with a diameter of 7.5 mm and 10 mm in length. This had been harvested from the centre of the vertebral bodies according to [18] with the aid of a core drill and a parallel saw. Lumbar vertebrae were fixed and centralized in a bench vise when the drilling was performed from the cover plate to the ground plate under visual inspection to ensure that these specimens consisted solely of trabecular bone. Compression was tested in the Sensotec (Columbus, Ohio) device and deformation in the MTS System (Berlin, Germany). Ultimate strain was measured at the point of failure. Young's modulus was calculated from the slope of the linear portion of the regression of the stress-strain relationship.
Bone Chemical Composition.
Ash, calcium, and phosphorus content were determined on the same crushed cylindrical sample of the 4th lumbar vertebra (L4) after mechanical testing for bone strength. Samples were dried for 4 h at 105 ∘ C to determine dry matter (%). The dried bone was ashed overnight in a muffle furnace at 450 ∘ C; the ash was weighed, dissolved in 20% (v/v) HCl. Calcium and inorganic phosphorus were analyzed as described previously. Bone fat content was determined on a cylindrical sample of exclusively trabecular bone of the last breast vertebra. The sample was ground, hydrolyzed with 4 M HCl, and extracted with petrol ether [19] . Analyses were done in duplicate and blindly.
2.7.
Histomorphometry. The 2nd lumbar vertebrae were used for histomorphometry [20] and evaluated for bone volume/tissue volume (BV/TV), trabecular width (Tb.Wi), trabecular separation (Tb.Sp), osteoid volume/tissue volume 
Results
Age, body weight, and characteristics of calcium and bone metabolism at baseline did not differ significantly between the groups (Tables 1-3 ). Animals on the deficient diet tended to lose weight by −1.4% after 5 months and by −3.7% after 15 months. Body weights in the control group remained stable (Table 2) .
Osteomalacia. Longitudinally BMD in vivo (mg/cm
3 ) decreased significantly in animals on the deficient diet (Figure 1(a) ). After 15 months, BMD had declined from baseline, equivalent to −10.6%. BMD of the control animals had declined, equivalent to −0.6%, and thus had remained stable. For calcium retention we observed a similar picture (Figure 1(b) ). The decline from baseline was significant after 5 months until the end. Compared to the controls, there was a trend for lower values at 5 and 10 which became significant at 15, when values of the control group had returned to initial values. The urinary phosphorus excretion increased significantly over time compared to stable values in the control group (Figure 1(c) ). In the deficient animals, osteoid surface was 55% higher than in controls at 15 ( < 0.05; Figure 2(a) ). At the same time most other bone values were slightly lower in deficient animals compared to controls (Table 4 ). There was a trend for lower bone wet and dry weights and slightly higher fat content and slightly lower ash weight and ultimate strain (Figures 2(b) and 2(c) ). OV/TV, ES/BS, Oc.S/BS, and N.Oc/T.Ar did not differ between groups (not shown). (Figure 3(b) ), whose values had slightly increased over the second time period. In the deficient group plasma PTH concentrations tended to be higher than in the control group between 8 and 13 ( Figure 3(c) ). In that time period their values slightly increased while those of the control group slightly decreased. Plasma calcium declined and was significantly lower than in the controls after 15 months (Table 2) . Urinary DPD slightly declined with time in the control group, but without being significantly different from the deficient group.
Vitamin D Status and Plasma and Urinary

Mineral Absorption.
After 5 months and until the end of the experiment, the fecal calcium excretion was significantly lower in the deficient group compared to the controls (Table 3 ) because of the low calcium content of that diet, amplified by the lack of vitamin D. These animals were in a negative calcium balance and had significantly lower values for calcium retention (Figure 1 ). Phosphorus intake (17.1 g/7d) was the same in both groups. Fecal phosphorus was highly variable in each group but did not differ between groups (Table 3 ).
Discussion
Of the many disorders that lead to rickets/osteomalacia, vitamin D deficiency and/or calcium insufficiency or its malabsorption are the most common [1, 21] [22] or is still limited to small children and the aged [23] . These doses did not take into account the pleiotropic effects of vitamin D [5, 24] . There are still open questions concerning vitamin D and calcium mediated effects on bone metabolism but also on extraskeletal issues like immunity, cardiovascular system, cancerogenesis, and central nervous system [1, 5] . Often effects and mechanisms can be more easily studied in animal models than in humans.
Animal Model.
The pig and minipig have long been known as models for biomedical and nutritional research [25] [26] [27] . The pig, like the human, is omnivorous and, having evolved like man with significant exposure to sunlight, photochemically converts 7-dehydrocholesterol to cholecalciferol. The rat, in contrast, is nocturnal, with ergocalciferol its main source of vitamin D, and therefore might be less well suited for the study of vitamin D metabolism [28] . Also, because of their size, minipigs can be utilized in routine apparatus for osteodensitometry to study bone health [11, 13] . Minipigs, unlike rats or sheep, develop glucocorticosteroidinduced osteoporosis (GIO) without the need for simultaneous ovariectomy [13] . We have shown earlier that GIO can be monitored by measurement of bone mineral density [11, 13] and is accompanied by changes in cartilage matrix [29] and bone tissue vascularisation [30] . Basal plasma 25(OH)D concentrations in the minipigs were 60 nmol/L and 75 nmol/L and thus were higher than concentrations in young men with very low vitamin D intakes of 200 IU/day but were comparable after the men had been supplemented with 1,800 IU/day. This amount refers to a total of 25 IU vitamin D/kg body wt/d compared with the 35 IU vitamin D/kg body wt/day in the minipigs. In young growing minipiglets plasma 25(OH)D concentrations of 340 nmol/L were observed when animals were on semisynthetic diets containing 8 g calcium/kg diet and 6,500 IU/kg diet vitamin D 3 , whereas their levels were 40 nmol/L after they had [39] , whereas in individuals without supplement plasma 25(OH)D concentrations remained at baseline. In these studies [34, 39] the plasma 25(OH)D level after supplementation was similar to the baseline level in the minipigs (about 75 nmol/L) when getting the standard diet but was achieved with less vitamin D/kg BW, possibly because of summertime dermal synthesis and resultant higher body stores. In minipigs concentrations after supplementation stabilized around 200 nmol/L, and such high values have also been reported for subjects at the end of the summer period after having had extended outdoor activities [40] . Since some years ago there is increasing agreement on a higher upper tolerable level of vitamin D intake without reaching toxicity and of higher plasma values of 25(OH)D without having adverse physiological effects [33, [40] [41] [42] [43] . This is also expressed in the elevation of the tolerable upper intake level (UL) of 2000 IU/d up to 4000 IU/d by the Institute of Medicine [1] . The supply with vitamin D of 2,400 IU/d in this trial remained below the upper tolerable level, even though the efficiency between vitamin D supply and plasma levels of 25(OH)D may be somewhat higher in young adult minipigs compared to aged adult humans. The plasma levels approximated a steady state after 15 months of supplementation, which is below the assumed level of toxicity of 500 nmol/L [42, 43] . This is in accordance with normocalcemia during intervention and lack of any other signs of toxicity in the animals. In order to attain mean 25(OH)D levels of about 50 nmol/L in the minipigs, about 23 ng/d (920 IU/D) might be sufficient, supposed that the Osteomalacia. In nutritional osteomalacia, defective bone mineralization leads to low BMD that might be similar to that in patients with osteoporosis [2, 8] and to a marked increase in nonmineralized bone matrix assessed histologically as osteoid volume or surface [21] . At the end of this experiment the minipigs on the deficient diet had developed hypovitaminosis D and lost bone mineral significantly according to longitudinal QCT-BMD. This loss was comparable to that in animals with GIO after 15 months on glucocorticosteroid treatment [13] , although the etiologies are quite different. Their osteoid surface was significantly higher (+55%), like in the human disease [8] , indicating that mild to moderate osteomalacia had developed within 15 months. BMD of minipigs is rather high [11, 13, 26] and in adult animals is about twice the value compared with human subjects [11] . This principal difference derogates a direct comparison of bone loss values between humans and minipigs. Minipigs are phenotypically more heterogenous than rodents and thus more animals are required to get the same statistical significance. The failure to reach significance for most crosssectional differences is owed to the small number of animals, which was yet sufficient for most parameters in longitudinal comparison when paired testing achieved higher sensitivity. This is well illustrated in case of BMD (longitudinally, change of values, significant, Figure 1 ; cross-sectionally, actual values, nonsignificant, Table 4 ). The present data, however, permit calculation of adequate sample size in future experiments. In contrast to animals with GIO whose urinary phosphorus and BAP had decreased, 25(OH)D had increased, and 1,25(OH) 2 D was unchanged [13] , these biochemical variables had increased (urinary phosphorus, 1,25(OH) 2 D), decreased (25(OH)D), or were unchanged (BAP) in the osteomalacic animals. Based on these biochemical variables nutritional osteomalacia can be discriminated from GIO in this large animal model despite similar bone loss. Table 1 . Significantly different from controls at a given time: Rickets in children may result from low calcium intakes even in the face of normal vitamin D status [1, 47] . In that situation body stores of vitamin D must be adequate [48] because the rise in 1,25(OH) 2 D, when dietary calcium is low, aggravates an increase in 25(OH)D catabolism [49] . This in turn is the basis for the need to accessorily increase vitamin D intake in children with calcium deficiency rickets [50] and may be the need to accessorily increase vitamin D intake in adults on chronically low calcium intakes.
Diagnosis of osteomalacia with the help of routine serum biochemical measures as predictors is not always clear-cut [51] , because abnormal values including plasma 25(OH)D may point to osteomalacia only in its severe form but miss the less severe disease [52] . Pronounced phosphaturia, typical for rickets and osteomalacia [6, 53] , has been observed in the deficient minipigs and may have aggravated BMD loss ( Figure 1 ). In the minipigs urinary calcium excretion, plasma PTH, and markers of bone turnover were found to have changed only slightly or nonsignificantly. This contrasts with what is typically found in patients, although with large variations [2, 21, 54, 55] . The hormonal state of the estrum cycle, which we did not assess or synchronize, could have contributed to the interindividual variations of bone markers or calcium metabolism-related hormones at the certain time points. However, it could not have differently affected the cumulative and final outcomes of the two groups, like osteoid surface, bone mineral density, and vitamin D status. The study period was a long-term observation covering 15 months and thus included several of the 21-day estrogen cycles in both groups.
The rise in PTH was delayed and less distinct, perhaps because of only a modest degree of hypovitaminosis D.
Furthermore, the rise of 1,25(OH) 2 D, as induced by the calcium insufficiency, is known to suppress PTH secretion [9] . The minipigs had a lower biological age compared with studies in the elderly or patients. Patients with a diagnosis of osteomalacia have most likely experienced nutritional or other deficiencies for many years, which may explain the more obvious clinical picture compared to the one obtained in the minipig trial.
We have to state the following limitations of the study. The assay for PTH was not specific for pigs, and thus results have to be verified in the future with porcine specific assays, even though PTH was specific enough in earlier studies to detect significantly higher values for ovariectomized pigs compared to intact controls [31] . In contrast to expectations from most observations in humans, BAP did not increase, which we cannot explain at the moment. However, BAP was specific enough to detect lower values than in control pigs after glucocorticosteroid [13] and bisphosphonate treatment [11] and to discriminate osteomalacic animals from animals with GIO [56] . Absolute values were comparable to those reported by others [57] . Therefore, comparison between and longitudinal changes within groups should be plausible in this experiment. We recognize that not all changes typically associated with osteomalacia in humans were statistically significant, because the number of animals was limited. This is valid for cross-sectional studies in particular.
In conclusion, we observed that nutritional osteomalacia and modulation of vitamin D metabolites and hypovitaminosis D can be induced and studied in minipigs when on a calcium and vitamin D deficient diet. The enlarged osteoid surface in combination with a significantly lower bone mineral density in the presence of hypovitaminosis D is characteristic of the human disease. The principal advantage of the minipig model over human studies is that the time course of the various parameters of osteomalacia and hypoor hypervitaminosis D can be evaluated over a moderately limited experimental period under controlled conditions, avoiding the problems of noncompliance beside others.
